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Abstract
Background: Dendrophthoe pentandra (L.) Miq. is a mistletoe species used in traditional medicine. Juice of leaves is
used in wound healing, skin infection and cancer; whereas the whole plant is used to treat hypertension and cough. D.
pentandra leaf extract has attracted interest due to its pharmacological properties including antioxidant, cytotoxicity
and anti-inflammatory effects. In this study, we have investigated the hepatopotective, antihyperglycemic and
antidiabetic potential of D. pentandra leaf extracts in rats.
Methods: D. pentandra leaf methanolic extract (DPLME) at a fixed dose of 400 mg/kg body weight was evaluated
for its effects on fasting glucose levels of rats. DPLME at the same dose was also used to determine the antidiabetic
potential in alloxan-induced diabetic rats and the hepatopotective effects on Paracetamol (PCM) intoxicated rats.
Results: Oral administration of DPLME exhibited a significantly notable oral glucose tolerance in rats. Single doses
of the DPLME displayed very significant antidiabetic activity which was comparable to the activity of the standard
antihyperglycemic agent Metformin (MET). DPLME also offered significant hepatoprotection to PCM-intoxicated rats
at levels commensurable to the standard hepatoprotective drug Silymarin (SIL).
Conclusions: The results of the present study showed that the DPLME possesses hepatopotective, antihyperglycemic
and antidiabetic activity. All these results could be due to the presence of the bioactive components in the extract and
this warrant further investigation on the nature of the phytochemical(s) responsible for the observed effects.
Keywords: Dendrophthoe pentandra, Oral glucose tolerance test, Antidiabetic activity, Hepatoprotective activity
Background
Dendrophthoe pentandra is a hemiparasitic woody shrub
that belongs to the Loranthaceae family of mistletoes and is
commonly found on tropical trees [1]. This plant has been
extensively used in folklore medicine despite being com-
monly considered as an unwanted plant due to its parasitic
nature. It is widely distributed in China, Cambodia, India,
Indonesia, Laos, Malaysia, Myanmar, Philippines, Thailand,
and Vietnam [2]. In Indonesia, the leaves of D. pentandra
has been reported used in the traditional medicine to treat
wounds and skin infection; while whole part of the plant is
used to cure hypertension and cough [3]. It is also used for
its antidiuretic activity in Indonesian traditional medicine
[1]. In Sulawesi Island, this plant has been used as medicine
to cure cancer [3]. Previous investigations on this species
have demonstrated that the D. pentandra leaf extract stim-
ulated the proliferation of mice splenocytes and thymocytes
in a time- and dose-dependent manner [4]. Artanti et al. re-
ported the antioxidant activity of this plant on the basis of
DPPH free radical scavenging ability and later confirmed
the exact chemical identity of the active antioxidant to be
quercetin-3-O-rhamnoside, a flavonol glycoside on the
basis of isolation and multiple spectrophotometric tech-
niques [2]. Consequent phytochemical analysis revealed
that flavonoids are the main active fraction of the leaf ex-
tracts of D. pentandra. The existence of other plant
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secondary metabolites including: saponins and tannins be-
ing present in extracts of solvents of varying polarity [1, 2].
There has been a worldwide upsurge in the incidence
of diabetes mellitus. It is projected to rise from 171 mil-
lion in 2000 to 366 million in 2030 [5]. Diabetes mellitus
is a metabolic disorder of multiple etiologies in which
chronic hyperglycemia results from absent or inadequate
pancreatic insulin secretion, with or without concurrent
impairment of insulin action [6]. Long-term complica-
tions associated with hyperglycemia, such as retinopathy,
neuropathy and angiopathy, result in significant disabil-
ity and mortality [7]. Standard treatments to tackle dia-
betes include recombinant insulin and oral antidiabetic
drugs, but these are faced with challenges such as ensur-
ing adequate production of insulin to meet the soaring
demands and difficult patient compliance due to the re-
current side effects of antidiabetic drugs [8, 9]. Hepatic
diseases refer to aberrations of the structure or changes
in the biochemical activity of liver cells. They occur in
almost every age group and account for a global mortal-
ity of one million in 2010 [10]. Despite the immense ad-
vancements in the field of modern medicine, the
absence of potent and effective hepatoprotective agents
has remained a constant issue [11].
A large number of medicinal preparations based on
plants are recommended for the treatment of hypergly-
cemia and for their hepatoprotective effect [12, 13]. The
World Health Organization (WHO) expert committee on
diabetes has listed as one of its recommendations that trad-
itional methods of treatment for diabetes should be further
investigated [14]. On the other hand, natural products are
also an invaluable pool of molecular scaffolds to discover
new drug leads and most currently marketed drugs derive
directly or indirectly from plant constituents [15]. As a part
of our ongoing research of pharmacological screening of
the Bangladeshi medicinal plants, the methanolic extract of
D. pentandra had been chosen for the present study. In this
study, we have investigated the hepatopotective, antihyper-
glycemic and antidiabetic potential of D. pentandra leaf ex-
tracts in rats for the first time. We concluded for further
study for the identification of key active compounds re-
sponsible for the observed effects.
Methods
Plant material
Fresh leaves of D. pentandra (L.) Miq were collected
from the Gazipur district, Bangladesh. Subsequent bo-
tanical identification and verification was completed at
the Bangladesh National Herbarium, Mirpur-1, Dhaka,
Bangladesh (DACB Accession no. 45823).
Preparation of the plant extracts
Leaves were thoroughly washed with water, chopped into
small pieces and air-dried for 4 days. The dried material
was ground to a fine powder and stored in an air-tight
container for further use. Extracts were prepared as de-
scribed previously [16]. Briefly, dried powdered D. pen-
tandra leaves (300 g) were extracted at room
temperature with methanol at a ratio of 1:4 (powder/
solvent) in a flat-bottom glass container with occasional
shaking for 4 days. The extracts were subsequently fil-
tered through a cotton plug and then through What-
man’s no.1 filter paper. The resulting filtrate was
concentrated to dryness under reduced pressure.
Animals
Swiss albino rats (80–115 g) of either sex, aged 7–8 weeks,
were purchased from the animal research branch of the
International Centre for Diarrhoeal Disease and Research,
Bangladesh (ICDDR’B). The animals were kept under
standard conditions of 25 ± 3 °C, relative humidity 35–
60% and on a 12 h dark/light cycle for 1 week before and
during the experiments. A standard rodent diet (Lipton,
India) was provided with ad libitum administration of
water. Food intake was withdrawn 18–24 h prior to the
start of the experiments. All experiments were performed
in accordance with the Ethical Principles and Guidelines
for Scientific Experiments on Animals (1995) formulated
by The Swiss Academy of Medical Sciences and the Swiss
Academy of Sciences. The experimental period lasted for
eight weeks.
Oral glucose tolerance test (OGTT)
Tests were carried out according to a previously de-
scribed protocol with some minor modifications [17].
Swiss albino rats that had fasted for 16 h prior to the ex-
periment were randomly divided into three groups each
containing four rats. Group III was orally administered
with DPLME 400 mg/kg body weight followed by oral
administration of 1 g/kg glucose solution. The standard
group (Group II) was treated with the antihyperglycemic
drug MET (Square Pharmaceuticals Ltd., Kaliakoir,
Bangladesh) at a dose of 50 mg/kg body weight, followed
by 1 g/kg oral glucose administration while the control
group (Group I) received no glucose solution. Blood
samples were subsequently collected from tail veins at 0,
30, 60, and 120 min following oral glucose administra-
tion and glucose levels were measured using a gluc-
ometer test strip [18].
Antidiabetic activity
The antidiabetic activity of DPLME was evaluated ac-
cording to a previously published method [19].
Non-diabetic and alloxan-induced diabetic rats were
used in the experiment and were divided into four
groups consisting of six rats in each group. Group I was
the non-diabetic control group, Group II was the
alloxan-induced diabetic control group. Diabetic rats in
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Group III were treated with MET 50 mg/kg body weight.
Diabetic rats in Group IV were orally administered with
DPLME at a concentration of 400 mg/kg body weight.
Following a period of 2 h, all rats were orally adminis-
tered of 1 g/kg glucose solution. All treatments were
carried out for seven consecutive days. At the end of the
experimental period, all surviving animals were fasted
overnight. Blood samples were collected from the tail
veins at 0, 30, 60, and 120 min following glucose admin-
istration for five successive days and glucose levels were
measured using a standard glucose oxidase test [20].
PCM-induced hepatotoxicity and analysis of liver function
parameters
The hepatoprotective activity of D. pentandra leaf ex-
tract was evaluated according to a previously published
method [21]. Rats were divided into four groups with
four rats in each group. Group I received no treatment
and served as the control group. Group II was adminis-
tered PCM (Beximco Pharmaceuticals Ltd., Tongi,
Bangladesh) in normal saline at a dose of 20 mg/kg body
weight. Group IV was orally administered with DPLME
at the dose of 400 mg/kg body weight. Group III was
treated with the hepatoprotective drug SIL (Radiant
Nutraceuticals Ltd., Dhaka, Bangladesh) at a dose of
40 mg/kg body weight. All treatments lasted for seven
consecutive days. On the fifth day of the respective treat-
ments, PCM at a dose of 20 mg/kg body weight was ad-
ministered and the animals were sacrificed 48 h later.
Blood samples were collected, allowed to clot and then
centrifuged to obtain serum samples. The levels of key
liver function parameters including aspartate amino-
transferase (AST), serum alanine aminotransferase
(ALT), total cholesterol and total protein were measured
using commercial assay kits (Span Diagnostic, Surat)
[22].
Statistical analyses
In all cases the experimental values are expressed as
mean ± SEM (Standard error of the mean). One-way
analysis of variance (ANOVA) followed by the Dunnett
Multiple Comparison t-test was used for statistical com-
parison. Here, p (p-value) ≤ 0.05 was considered as sta-
tistically significant difference when any group of rats
compared with the control group rats. All statistical ana-
lysis was done using GraphPad Prism software (version
5.01) from GraphPad Software, Inc., San Diego Califor-
nia, USA.
Results
Oral glucose tolerance test (OGTT)
The results of the OGTT performed in rats are sum-
marised in Table 1 and illustrated in Fig. 1. We observed
that at the ultimate 120 min interval following oral
glucose intake, the rats that had received the DPLME
400 mg/kg was able to metabolise glucose more effi-
ciently than those in the standard group that had re-
ceived the antihyperglycemic drug MET 50 mg/kg. The
blood glucose levels of rats from group III decreased sig-
nificantly in compared to the control group I (p < 0.05).
The rats from group III, in particular, that had received
the DPLME showed a greater ability to metabolise glu-
cose as depicted by the sharp reduction in their blood
glucose levels at different intervals throughout the entire
time span of 120 min.
Antihyperglycemic activity
The data obtained are summarized in Table 2 and illus-
trated in Fig. 2. We observed that the rats from Group
IV treated with DPLME showed distinctly reduced blood
glucose levels compared with the diabetic control group
(p < 0.001). Animals in Group IV treated with the
DPLME 400 mg/kg had the lowest blood glucose levels
throughout the entire five-day period. The progression
rate in the decrease of blood glucose levels in rats of
Group IV was found to parallel that observed in the rats
of Group III that had received the standard antihypergly-
cemic drug MET. From the third day of administration
onwards, we found that the DPLME 400 mg/kg (Group
IV) could lower blood glucose in diabetic rats to a level
that is comparable to the steady blood glucose level of
non-diabetic rats (Group I). On the fifth day of adminis-
tration, the rats in Group IV also had blood glucose
levels lower than that in the corresponding control
group (Group I) and the group receiving the MET
(Group III). This data demonstrates an evident
anti-hyperglycemic activity and a potential anti-diabetic
role of DPLME.
Effects of extracts on key liver function parameters
The results of the protective effect of D. pentandra
extracts on PCM-induced hepatotoxicity are shown in
Table 3 and illustrated in Fig. 3. The rats that had re-
ceived DPLME (group IV) along with the rats treated
with the hepatoprotective drug, SIL (group III)
showed liver function parameters at levels similar to
the untreated control group (group I). However, the
rats from Group IV treated with DPLME at a concen-
tration of 400 mg/kg displayed distinct reductions in
the levels of the different liver function parameters
compared with the PCM-intoxicated group (Group II)
and to levels that are comparable to the levels ob-
served for the group treated with the standard hepa-
toprotective drug, SIL (group III) (p < 0.05).
Therefore, it can be suggested that DPLME offers
hepatoprotection up at a concentration of 400 mg/kg
at levels commensurable to that observed for SIL.
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Discussion
Medicinal plants have remained integral components of
traditional systems of medicine in many countries
worldwide and are still relied upon today for various
healthcare and medicinal needs [23]. Many plant-derived
substances can serve as leads or precursors for the syn-
thesis of modern drugs and have been reported to allevi-
ate a range of ailments including diabetes and hepatic
injuries [24, 25]. Hyperglycemia is the result of either in-
sulin deficiency or insulin resistance that confers a re-
duced ability of liver and muscle cells to store glucose
[26]. Though oral antihyperglycemic agents are widely
used in practice, they present some disadvantages owing
to their poor pharmacokinetic attributes and accom-
panying side effects [27].
Several biological activities of the extracts of D.
pentandra have been already reported in a number
of previous literatures. According to Endharti et al.,
the D. pentandra methanolic leaf extract containing
quercetin has therapeutic potential to ameliorate
TNBS (2,4,6-trinitrobenzene sulfonic acid) induced
colitis syndrome in mice. It was also reported that
the same extract can inhibit the differentiation of
Th17 cells by inhibiting IL-17 production. These
findings suggest that the extract of this plant has
the important role in inhibiting intestinal inflamma-
tion [1]. Extracts of D. pentandra have also been
reported to effectively inhibit inflammation, prolif-
eration and induce p53 expression on mice models
of colitis-associated colon cancer [28].Analysis of
cytotoxicity revealed that the extracts of D. pentan-
dra had cytotoxic effects on K562 and MCM-B2
cell lines thus suggestive of a potential anticancer
activity of this plant [29]. Methanolic extracts of D.
pentandra leaves have been also found to exert po-
tent anti-proliferative effects on BCR/ABL-Positive
and Imatinib Resistant Leukemia Cell lines [30]. On
the other hand, Artanti et al. observed significant
antioxidant activities for the methanolic extracts
and identified an active flavonol glycoside,
quercetin-3-O-rhamnoside as antioxidant where as
anti-diabetic activity had been exhibited by both the
methanolic and aqueous extracts [3].
In our OGTT, which measures the body’s ability to
metabolise glucose and clear it out of the blood-
stream [17], D. pentandra methanolic leaf extracts
showed prominent activity. Extracts also exhibited
some potential for controlling diabetes via significant
antihyperglycemic activity at a concentration of
400 mg/kg in comparison to the standard drug MET,
an oral antihyperglycemic agent used in addition to
regulation in diet and exercise for the management of
type 2 (non-insulin dependent) diabetes mellitus [31].
It has been already discussed that the main active
bioactive components in the D. pentandra leaf extract
are flavonoids. Presence of flavonoids in the D. pen-
tandra extract explains its different biological and
pharmacological activities [1, 2]. According to Fitrilia
et al., different extracts of D. pentandra was found
out to be rich in flavonoids, tannins and saponins
[32]. Most recently, Yee et al. in [33] also reported
the presence various phytochemicals including alka-
loids, flavonoids, saponins, and tannins in the ethyl
acetate leaf extract of this plant. Other extracts of
plants indigenous to the Indian sub-continent such
as, Allium cepa, Allium sativum, Cajanus cajan,
Coccinia indica, have been attributed some
Table 1 Effect of methanolic leaf extract of D. pentandra on fasting Rats after oral glucose intake
Groups Serum glucose level (mg/dl)
0 min 30 min 60 min 120 min
Group I: Control group 90.18 ± 1.32 261.00 ± 2.22 275.40 ± 2.34 291.60 ± 1.68
Group II: MET 50 mg/kg 91.98 ± 1.20 142.20 ± 0.66* 133.20 ± 0.90* 135.00 ± 1.14*
Group III: DPLME 400 mg/kg 126.00 ± 7.44 111.60 ± 3.78* 117.00 ± 4.62* 103.50 ± 4.08*
Data are expressed as mean ± standard error of the mean (SEM) (n = 4). * p < 0.05 denotes statistically significant result for a group when it was compared with
the hyperglycemic control group (Group I)
Fig. 1 Effects of D. pentandra leaf methanolic extract on fasting rats
after oral glucose intake. Values are expressed as mean ± SEM (n = 4).
* p < 0.05 denotes statistically significant result for a group when it
was compared with the hyperglycemic control group (Group I)
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anti-hyperglycemic activity and it has been suggested
that the presence of phytochemicals such as flavo-
noids, alkaloids and other phenolics may contribute
to the activity [34]. Indeed, the role of flavonoids has
already been reported in the stimulation of peripheral
glucose uptake, enhancement of lipogenesis and facili-
tation of insulin release and conversion from
pro-insulin to insulin [35]. Considering all these stud-
ies, it can be concluded that the antidiabetic and anti-
hyperglycemic activities of the methanolic leaf extract
of D. pentandra is mostly associated with its flavo-
noids content. These studies also suggest that D. pen-
tandra methanolic leaf extracts could either stimulate
the pancreatic insulin secreting cells or improve the
receptor responsiveness of tissues to insulin for an in-
creased glucose uptake. Alloxan is a chemical that
confers its toxicological effects by the selective necro-
sis of pancreatic islet cells, leading to a 3 to 4 times
increase in blood glucose levels compared to the un-
treated animals [36, 37]. It is possible that the admin-
istration of D. pentandra methanolic leaf extracts to
alloxan-induced diabetic animals leads to elevated
insulin secretion from regenerated or remnant beta
cells or augmented stimulation of glucose uptake by
peripheral tissues [38, 39].
The liver plays a vital role in the detoxification of a
wide range of xenobotics [40]. Liver damage mediated
by the excessive exposure to drugs (e.g. high doses of
paracetamol) and environmental pollutants leads to cel-
lular necrosis, plasma membrane damage, depletion in
glutathione (GSH) levels accompanied with elevated
levels of serum markers of liver damage such as ALT,
AST and alkaline phosphatase (ALP) [41]. The rise in
total cholesterol, total bilirubin and hypoproteinemia are
also key features of liver damage in PCM-intoxicated
rats [42, 43]. Several indigenous medicinal plants from
the Indian sub-continent including, Bixa orellana, Caja-
nus cajan, Glycosmis pentaphylla and Casuarina equise-
tifolia are known to possess some hepatoprotective
activity [44]. In our study, PCM-treated rats showed a
significant rise in the levels of their liver function param-
eters (AST, ALT, total cholesterol, and total protein)
while the levels were significantly lowered following ad-
ministration of D. pentandra methanolic leaf extracts.
Table 2 Effect of methanolic leaf extract of D. pentandra on Alloxan induced diabetic Rats
Groups Serum glucose level (mg/dl)
Day 1 Day 2 Day 3 Day 4 Day 5
Group I: Nondiabetic control 91.80 ± 1.02*** 102.06 ± 2.82*** 89.64 ± 0.78*** 99.00 ± 2.10*** 90.00 ± 1.56***
Group II: Diabetic control 209.70 ± 2.52 256.14 ± 1.86 308.88 ± 2.94 261.72 ± 1.92 322.74 ± 3.06
Group III: MET 50 mg/kg 224.28 ± 4.02 157.50 ± 1.86*** 99.54 ± 1.62*** 80.28 ± 0.84*** 76.68 ± 1.92***
Group IV: DPLME 400 mg/kg 125.28 ± 3.24*** 112.68 ± 2.28*** 104.40 ± 1.68*** 95.04 ± 1.14*** 77.40 ± 1.62***
Data are expressed as mean ± SEM values (n = 6). *** p < 0.001 denotes statistically very significant result for a group when it was compared with the control
group (Group II)
Fig. 2 Effects of D. pentandra leaf methanolic extract on blood glucose
levels in non-diabetic and diabetic rats. Values are expressed as mean ±
SEM (n= 6). *** p< 0.001 denotes statistically very significant result for a
group when it was compared with the control group (Group II)
Table 3 Effect of methanolic leaf extract of D. pentandra on key
liver function parameters of Rats having PCM induced hepatotoxicity
Groups AST (U/L) ALT (U/L) Total
cholesterol
(mg/dl)
Total protein
(U/L)
Group I:
Control
33.75 ± 7.28* 47.28 ± 5.26* 114.00 ± 2.79* 4.83 ± 1.01*
Group II:
PCM
20 mg/
kg
127.75 ± 17.18 169.21 ± 16.71 136.50 ± 6.10 8.07 ± 2.09
Group
III: SIL
40 mg/
kg
40.88 ± 3.42* 45.82 ± 6.59* 116.61 ± 9.89* 2.41 ± 0.54*
Group
IV:
DPLME
400 mg/
kg
108.39 ± 6.30* 129.34 ± 11.06* 112.00 ± 4.30* 5.74 ± 0.84
Data are expressed as mean ± SEM (n = 4). * p < 0.05 denotes statistically
significant results for a group when it was compared with the PCM group
(Group II)
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This hepatoprotective effect was comparable to the one
observed for rats treated with silymarin, a popular hepato-
protective herbal remedy prepared from Silybum maria-
num (milk thistle) [45, 46]. Various secondary metabolites
have been identified in the leaf extract of D. pentandra in-
cluding flavonoids, alkaloids, saponins and tannins. Flavo-
nol glycosides i.e., quercetin-3-O-rhamnoside was also
isolated from this plant extract [2, 32, 33]. These second-
ary metabolites have been reported to be associated with
the hepatoprotective effects of different medicinal plants
[47, 48]. The observed hepatoprotective effect of D. pen-
tandra extract might be associated with the presence of
these flavonol as well as other secondary metabolites. It is
possible that D. pentandra extracts help improve the func-
tions of hepatocytes by stabilising cell membranes and/or
enhancing the regeneration of parenchymal cells [11].
Overall, this suggests that D. pentandra methanolic leaf
extracts can effectively control liver damage and restore
liver functions.
Conclusions
Our results have highlighted, for the first time, the anti-
hyperglycemic, antidiabetic and hepatoprotective activity
of the methanolic extract of D. pentandra leaves in vivo.
Further research aimed at the elucidation of key phyto-
chemicals responsible for the observed effects is
necessary to consolidate the use of this medicinal plant
as a therapeutic option for the treatment of hepatic
injuries and diabetes.
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